Adult and Pediatric Hemoconcentrators Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Adult and Pediatric Hemoconcentrators Market Size

Adult and Pediatric Hemoconcentrators Market is anticipated to witness substantial growth through 2032 owing to the product demand among perfusionists and surgeons engaged in cardiopulmonary surgeries.
 

The adoption of hemoconcentrators is driven by the imperative to maintain elevated hematocrit levels, thereby reducing reliance on additional blood products. The global surge in heart diseases, the leading cause of global mortality according to the World Health Organization (WHO), with approximately 17.9 million deaths annually, intensifies the demand for hemoconcentrators during bypass surgeries.
 

Surgeons employ this device to extract fluids during cardio bypass surgery, mitigating the risk of edema, organ dysfunction, and protein concentration. The high incidence of cardiovascular diseases in low-income countries underscores the need for cost-effective cardiac care solutions. The innovative hemoconcentrator devices from various companies, aimed at enhancing patient care quality.
 

Adult and Pediatric Hemoconcentrators Market Trends

A significant trend in the market is the continuous innovation in hemoconcentrator devices as many companies are launching advanced versions of these devices to enhance patient care quality, improving their acceptance among end-users in the healthcare sector. This reflects a commitment to addressing evolving clinical needs and optimizing surgical outcomes.
 

The rising prevalence of congenital heart ailments in children and the expanding elderly population further propel the progress of the industry. Nevertheless, geopolitical tensions, such as those between Russia and Ukraine, disrupt market trends by delaying heart surgeries due to the redirection of healthcare resources to address conflict-related injuries, limiting patients' access to essential medical facilities.
 

Adult and Pediatric Hemoconcentrators Market Analysis

In terms of type, the adult hemoconcentrator segment is poised to grow through 2032, driven by factors like escalating obesity rates among older adults in rural areas. Obesity, identified as a risk factor for heart failure, stimulates the use of adult hemoconcentrators in cardiac surgery for obese patients. As per the Trust for America’s Health (TFAH) annual report for 2022, obesity rates exceeded 35% in 19 states in the United States. This factor is expected to stimulate the utilization of adult hemoconcentrators for conducting cardiac surgery in patients with obesity.
 

In terms of end-use, the ambulatory surgical centers segment will expand significantly through 2032 as these centers present numerous advantages for individuals undergoing heart surgery, including superior surgical treatment and a reduction in surgical site infections. The expansion of the ASC network is notable, as it adapts to the increasing influx of patients seeking treatment for cardiovascular conditions.
 

In the Asia Pacific region, the adult and pediatric hemoconcentrators market foresees a substantial revenue increase by 2032, propelled by surging healthcare expenditure, rising per capita income, and a high incidence of cardiovascular diseases. Improvements in coronary artery bypass grafting procedures contribute to the growing deployment of hemoconcentrator devices in the region.
 

Adult and Pediatric Hemoconcentrators Market Share

Key players in the market, including Nipro, Medtronic, Andocor, MAQUET (Getinge), Medivators (Cantel Medical Corporation), Terumo Cardiovascular Systems, and Sorin, employ diverse strategies such as mergers, new product launches, partnerships, and acquisitions to expand their business operations.
 

Adult and Pediatric Hemoconcentrators Industry News

• In January 2023, Terumo and Siemens Healthineers India partnered to improve the cardiac care in India using collaborative interventions.

What Information does this report contain?